Skip to main content
. 2021 May 15;13(5):5412–5419.

Table 4.

Comparison of adverse drug reactions in patients

Weight gain Menstrual changes Mammary swelling pain Nausea and vomiting Dizziness and hypodynamia The total incidence
Early-stage endometrial carcinoma The control group (n=25) 1 (4.0) 3 (12.0) 2 (8.0) 1 (4.0) 2 (8.0) 9 (36.0)
The combination group (n=31) 0 (0) 2 (6.5) 1 (3.2) 1 (3.2) 0 (0) 4 (12.9)
χ2/t 8.0953
P 0.0441
Atypical endometrial hyperplasia The control group (n=20) 1 2 1 2 1 7
The combination group (n=27) 0 1 1 0 1 3
χ2/t 3.9151
P 0.0479